The Gut Punch Weekly #4Massive study catalogues GLP-1's many benefits & risks, Medicare targets Ozempic for price cuts, high-dose Wegovy shows promising weight loss results, and more!Lance LivelyJan 22, 2025∙ Paid1ShareContinue reading this post for free, courtesy of Lance Lively.Claim my free postOr purchase a paid subscription.PreviousNext
